During the corresponding time, Rosecliff Acquisition Corp I saw a revenue deteriorated by -30.42 % year on year, sequentially revenue fell by -11.7 %. While revenue at the Rosecliff Acquisition Corp I's corporate clients
Rosecliff Acquisition I's Comment on Sales, Marketing and Customers
The company provides the DeepView System, a diagnostic tool designed to assist healthcare professionals in assessing the healing potential of burn wounds. The system utilizes patented multi-spectral optics and artificial intelligence algorithms to classify wound tissue as healing or non-healing, allowing clinicians to make immediate and objective evaluations. Its primary market includes medical professionals specializing in wound care, particularly for burn injuries. The company has received financial support from U.S. government agencies including the Biomedical Advanced Research and Development Authority (BARDA) within the Office of the Assistant Secretary for Preparedness and Response (HHS ASPR), the National Science Foundation (NSF), the National Institutes of Health (NIH), the Defense Health Agency, and the Department of Defense.
: Spectral AI, Inc., an innovative player in the medical diagnostics field utilizing artificial intelligence (AI) for enhanced wound care decision-making, has announced the addition of three new U.S. clinical trial sites. The inclusion of these sites is poised to expedite patient enrollment and the subsequent advancement of their 2024 Burn Pivotal Study. This strategic move is expected to significantly impact both the company’s operational tempo and the broader medical community’s approach to burn diagnostics and care. Spectral AI, Inc. (Nasdaq: MDAI) has made considerable strides in harnessing the power of AI to revolutionize medical diagnostics. The company s latest development involves the expansion ...
Spectral AI Collaborates with PolyNovo to Introduce DeepView System for Burn Indication in AustraliaDallas-based artificial intelligence company, Spectral AI, has recently announced its collaboration with global wound care company, PolyNovo, to introduce the DeepView System for burn indication to the Australian market. Spectral AI, known for its AI-based medical diagnostics solutions that aid in faster and more accurate treatment decisions in wound care, has signed a Memorandum of Understanding (MOU) with PolyNovo to facilitate a potential limited deployment of the DeepView System in Australia.The partnership between Spectral AI and PolyNovo holds significant implications for both companies. By developing t...
Spectral AI Achieves 100% Pediatric Enrollment in Pivotal U.S. Burn Study Dallas, July 2, 2024 Spectral AI, Inc. (Nasdaq: MDAI), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced a significant milestone in its 2024 pivotal study by achieving 100% pediatric patient enrollment at burn centers. This achievement marks a critical step towards validating the AI-driven algorithm employed by its DeepView System for burn indications.The company has been on an aggressive timeline to enroll patients in its pivotal study, which is designed to demonstrate the efficacy and accuracy of the DeepView System s proprietary im...
Artificial Intelligence s influence on the medical sector has been nothing short of transformative, allowing for faster, more precise, and more efficient procedures and diagnostics. An essential player in this evolution, Spectral MD, Inc. (SMD), an AI company notably dedicated to enhancing medical diagnostics in wound care, is setting its sights on moving on to the next stage of global expansion.Hailing from Dallas, Texas, the subsidiary of Spectral AI, Inc. (NASD: MDAI; MDAIW), SMD, revealed their most recent strategic move on January 29, 2024. The company announced that it has submitted an application for their innovative predictive software, DeepView AI-Burn, to become registered as UK Conformity Assessed...
Rosecliff Acquisition I’s Comment on Sales, Marketing and Customers
The company provides the DeepView System, a diagnostic tool designed to assist healthcare professionals in assessing the healing potential of burn wounds. The system utilizes patented multi-spectral optics and artificial intelligence algorithms to classify wound tissue as healing or non-healing, allowing clinicians to make immediate and objective evaluations. Its primary market includes medical professionals specializing in wound care, particularly for burn injuries. The company has received financial support from U.S. government agencies including the Biomedical Advanced Research and Development Authority (BARDA) within the Office of the Assistant Secretary for Preparedness and Response (HHS ASPR), the National Science Foundation (NSF), the National Institutes of Health (NIH), the Defense Health Agency, and the Department of Defense.
Sources:
Rosecliff Acquisition Corp I’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Rosecliff Acquisition Corp I’s corporate clients.
For your research, we’ve provided 9 tables on Rosecliff Acquisition Corp I corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
